These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


507 related items for PubMed ID: 34204131

  • 1. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
    Chiappini S, Mosca A, Miuli A, Santovito MC, Orsolini L, Corkery JM, Guirguis A, Pettorruso M, Martinotti G, Di Giannantonio M, Schifano F.
    Medicina (Kaunas); 2021 Jun 06; 57(6):. PubMed ID: 34204131
    [Abstract] [Full Text] [Related]

  • 2. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
    Gray R, Bressington D, Hughes E, Ivanecka A.
    J Psychiatr Ment Health Nurs; 2016 Jun 06; 23(5):267-81. PubMed ID: 27037639
    [Abstract] [Full Text] [Related]

  • 3. Next generation of novel psychoactive substances on the horizon - A complex problem to face.
    Zawilska JB, Andrzejczak D.
    Drug Alcohol Depend; 2015 Dec 01; 157():1-17. PubMed ID: 26482089
    [Abstract] [Full Text] [Related]

  • 4. The clinical challenges of synthetic cathinones.
    Schifano F, Napoletano F, Arillotta D, Zangani C, Gilgar L, Guirguis A, Corkery JM, Vento A.
    Br J Clin Pharmacol; 2020 Mar 01; 86(3):410-419. PubMed ID: 31674690
    [Abstract] [Full Text] [Related]

  • 5. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
    Palamar JJ, Martins SS, Su MK, Ompad DC.
    Drug Alcohol Depend; 2015 Nov 01; 156():112-119. PubMed ID: 26377051
    [Abstract] [Full Text] [Related]

  • 6. [Bonzai, lead and bath salt-poisoning with new and old drugs : Synthetic amphetamines, cathinones, cannabinoids and opioids-an overview].
    Strube J, Schaper A.
    Med Klin Intensivmed Notfmed; 2019 Nov 01; 114(8):684-692. PubMed ID: 29404633
    [Abstract] [Full Text] [Related]

  • 7. Synthetic cathinones: a new public health problem.
    Karila L, Megarbane B, Cottencin O, Lejoyeux M.
    Curr Neuropharmacol; 2015 Jan 01; 13(1):12-20. PubMed ID: 26074740
    [Abstract] [Full Text] [Related]

  • 8. The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review.
    Orsolini L, Chiappini S, Corkery JM, Guirguis A, Papanti D, Schifano F.
    Expert Rev Neurother; 2019 Dec 01; 19(12):1253-1264. PubMed ID: 31503507
    [Abstract] [Full Text] [Related]

  • 9. Recreational use, analysis and toxicity of tryptamines.
    Tittarelli R, Mannocchi G, Pantano F, Romolo FS.
    Curr Neuropharmacol; 2015 Jan 01; 13(1):26-46. PubMed ID: 26074742
    [Abstract] [Full Text] [Related]

  • 10. Emerging Agents of Substance Use/Misuse.
    Michienzi AE, Borek HA.
    Emerg Med Clin North Am; 2022 May 01; 40(2):265-281. PubMed ID: 35461623
    [Abstract] [Full Text] [Related]

  • 11. Emergency department visits due to new psychoactive substances and other illicit drugs in Taiwan: preliminary results of the Taiwan Emergency Department Drug Abuse Surveillance (TEDAS) project.
    Lin CC, Weng TI, Ng CJ, Shih CP, Hsu J, Liao YC, Yang CC, Fang CC, TEDAS Research Group.
    Clin Toxicol (Phila); 2022 Jun 01; 60(6):708-715. PubMed ID: 35315299
    [Abstract] [Full Text] [Related]

  • 12. The Growing Problem of New Psychoactive Substances (NPS).
    Madras BK.
    Curr Top Behav Neurosci; 2017 Jun 01; 32():1-18. PubMed ID: 27571747
    [Abstract] [Full Text] [Related]

  • 13. New and Emerging Illicit Psychoactive Substances.
    Graddy R, Buresh ME, Rastegar DA.
    Med Clin North Am; 2018 Jul 01; 102(4):697-714. PubMed ID: 29933824
    [Abstract] [Full Text] [Related]

  • 14. NPS: Medical Consequences Associated with Their Intake.
    Schifano F, Orsolini L, Papanti D, Corkery J.
    Curr Top Behav Neurosci; 2017 Jul 01; 32():351-380. PubMed ID: 27272067
    [Abstract] [Full Text] [Related]

  • 15. New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic.
    Lo Faro AF, Berardinelli D, Cassano T, Dendramis G, Montanari E, Montana A, Berretta P, Zaami S, Busardò FP, Huestis MA.
    Biology (Basel); 2023 Feb 08; 12(2):. PubMed ID: 36829550
    [Abstract] [Full Text] [Related]

  • 16. Designer drugs: a medicinal chemistry perspective (II).
    Carroll FI, Lewin AH, Mascarella SW, Seltzman HH, Reddy PA.
    Ann N Y Acad Sci; 2021 Apr 08; 1489(1):48-77. PubMed ID: 32396701
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of cathinones and other new psychoactive substances in hair of parents and children of families with known or suspected parental abuse of conventional illegal drugs.
    Niebel A, Pragst F, Krumbiegel F, Hartwig S.
    Forensic Sci Int; 2022 Feb 08; 331():111148. PubMed ID: 34923263
    [Abstract] [Full Text] [Related]

  • 18. Synthetic drugs of abuse.
    Tamama K.
    Adv Clin Chem; 2021 Feb 08; 103():191-214. PubMed ID: 34229850
    [Abstract] [Full Text] [Related]

  • 19. New/emerging psychoactive substances and associated psychopathological consequences.
    Schifano F, Napoletano F, Chiappini S, Guirguis A, Corkery JM, Bonaccorso S, Ricciardi A, Scherbaum N, Vento A.
    Psychol Med; 2021 Jan 08; 51(1):30-42. PubMed ID: 31327332
    [Abstract] [Full Text] [Related]

  • 20. Death cases involving certain new psychoactive substances: A review of the literature.
    Kraemer M, Boehmer A, Madea B, Maas A.
    Forensic Sci Int; 2019 May 08; 298():186-267. PubMed ID: 30925344
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.